Predict your next investment

Asset/Investment Management

See what CB Insights has to offer

Investments

15

Funds

1

About Panacea Venture

Panacea Venture (瑞伏医疗) is an investment firm focused on healthcare ventures in China.

Panacea Venture Headquarter Location

PO BOX 309 Ugland House

Grand Cayman, KY1-1104,

Cayman Islands

8613816580525

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Panacea Venture News

Panacea Venture Investments

15 Investments

Panacea Venture has made 15 investments. Their latest investment was in Yizun as part of their Series A on January 1, 2022.

CBI Logo

Panacea Venture Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/11/2022

Series A

Yizun

Yes

1

11/15/2021

Seed VC

Velavigo

$50M

Yes

7

10/9/2021

Seed

Jirui Healthcare

Yes

1

9/27/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

7/26/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/11/2022

11/15/2021

10/9/2021

9/27/2021

7/26/2021

Round

Series A

Seed VC

Seed

Series A - II

Seed VC

Company

Yizun

Velavigo

Jirui Healthcare

Subscribe to see more

Subscribe to see more

Amount

$50M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

7

1

10

10

Panacea Venture Fund History

1 Fund History

Panacea Venture has 1 fund, including Panacea Venture Healthcare Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/28/2019

Panacea Venture Healthcare Fund I

Early-Stage Venture Capital

Closed

$180M

4

Closing Date

5/28/2019

Fund

Panacea Venture Healthcare Fund I

Fund Type

Early-Stage Venture Capital

Status

Closed

Amount

$180M

Sources

4

Panacea Venture Team

1 Team Member

Panacea Venture has 1 team member, including current Managing Partner, James Zuie-chin Huang.

Name

Work History

Title

Status

James Zuie-chin Huang

Vivo Capital, Anesiva, Corgentech, Tularik, and GlaxoSmithKline

Managing Partner

Current

Name

James Zuie-chin Huang

Work History

Vivo Capital, Anesiva, Corgentech, Tularik, and GlaxoSmithKline

Title

Managing Partner

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.